×

Do you want to link to this External Site and leave Amgen.com?

YOU ARE NOW LEAVING AMGEN'S WEB SITE. Amgen takes no responsibility for, and exercises no control over, the organizations, views, or accuracy of the information contained on this server or site.

×

Do you want to link to this External Site and leave Amgen.com?

YOU ARE NOW LEAVING AMGEN'S WEB SITE. Amgen takes no responsibility for, and exercises no control over, the organizations, views, or accuracy of the information contained on this server or site.

×

Do you want to link to this External Site and leave Amgen.com?

YOU ARE NOW LEAVING AMGEN'S WEB SITE. Amgen takes no responsibility for, and exercises no control over, the organizations, views, or accuracy of the information contained on this server or site.

×

Do you want to link to this External Site and leave Amgen.com?

YOU ARE NOW LEAVING AMGEN'S WEB SITE. Amgen takes no responsibility for, and exercises no control over, the organizations, views, or accuracy of the information contained on this server or site.

Adverse Event and Product Complaint Reporting

Part of Amgen's mission to serve patients includes collecting, reviewing and reporting all Adverse Event or Adverse Experience (AE) information associated with the use of Amgen's investigational or marketed products. An AE is any untoward medical occurrence in a patient or clinical investigation subject administered a pharmaceutical product and which does not necessarily have to have a causal relationship with the treatment. It is Amgen's policy to comply with all regulations and laws worldwide relating to AE reporting. Individuals subject to this policy are required to report AEs within one business day of learning of the AE.

An AE can be any unfavorable and unintended sign (including an abnormal laboratory finding, for example), symptom, or disease temporally associated with the use of a medicinal product, whether or not considered related to the medicinal product. This includes:

  • Any clinically significant worsening of a pre-existing condition;
  • An AE occurring from medication error or overdose of a product, whether accidental or intentional;
  • An AE occurring from abuse (i.e., use for non-clinical reasons) of a product;
  • An AE that has been associated with the discontinuation of the use of a product; and
  • Any lack or loss of intended effect.

This Policy applies to Covered Persons involved in any activities and programs that may collect adverse event information, including, for example but not limited to, market research activities, patient support programs, and arrangements with specialty pharmacies.

All information that pertains to an AE must be directed to Amgen for review and analysis as appropriate.

Report adverse events related to any Amgen product to Amgen by calling 800-77-AMGEN (800-772-6436) if you reside in the U.S. or 866-50-AMGEN (866-502-6436) if you reside in Canada.

Patients in other countries are encouraged to contact their local Amgen office or contact Amgen's U.S. Medical Information Department by calling +1 805 447-3505.

Fax: +1-888-814-8653

Adverse Event and Product Complaint Reporting